Compass Therapeutics, Inc. (CMPX) NASDAQ

2.46

-0.01(-0.40%)

Updated at March 14 04:00PM

Currency In USD

Valuation

Market Cap198.16M
Enterprise Value175.67M
P/E Ratio-7.09
PEG Ratio-0.07
Price/Sales Ratio92.09
Price/Book Ratio2.45
Enterprise/Revenue83.99
Enterprise/EBITDA-5.79

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-12.93
Operating Margin-15.01

Management Effectiveness

Return On Assets-0.32
Return On Equity-0.32

Income Statement

Revenue0
Revenue/Share0.03
Gross Profit-1.89M
EBITDA-48.47M
Net Income-42.49M
Diluted EPS-0.33

Balance Sheet

Total Cash135.4M
Total Cash/Share0.98
Total Debt6.88M
Total Debt/Equity0.05
Current Ratio31.84
Book Value Per Share1.01

Price History

52-Week Change7.42
52-Week High4.08
52-Week Low0.77
Moving Average 50 Days2.74
Moving Average 200 Days1.75

Statistics

Average Volume1.46M
Shares Outstanding138.28M
% Held by Institutions73.67

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A